Contraceptive Pills Market Opportunities, Drivers, Top Players, Analysis and Forecasts Till 2022

Contraceptive Pills Market Opportunities, Drivers, Top Players, Analysis and Forecasts Till 2022
Contraceptive Pills Market report analysis is done by experts which gives in-depth detail information about the Contraceptive Pills Market industry segmentation, regional data & industry key players.

Anti-conception medication pills which are also called as oral contraceptive pills are a kind of female hormonal anti-conception medication technique and are extremely viable at avoiding pregnancy. These pills are small tablets that a patient swallow every day. These birth control pills are been used from ancient times but the save and effective methods are introduce and available from 20th century. Contraceptive drugs are used to prevent the unwanted pregnancy by blocking the normal process of ovulations or by altering the process which support the fertilization of egg. Most pills contain two sorts of manufactured (man-made) female hormones: estrogen and progestin.

Globally the market for contraceptive Pills is growing steadily and has a bright future. Globally the market for contraceptive Pills is expected to grow at the rate of about around 2.2% from 2016 to 2022.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/2122

Contraceptive Pills Market Key Players

This are some of the prominent players at the forefront of competition in the Global Contraceptive Pills Market and are profiled in MRFR Analysis.

  • Merck & Co.
  • Inc (US)
  • Pfizer Inc (US)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Bayer AG (Germany)
  • Allergan plc. (Ireland)
  • Janssen Global Services llc. (US)
  • Mankind Pharma Ltd. (India)
  • Piramal Enterprises Ltd (India)
  • Reckitt Benckiser Plc (UK)
  • Church & Dwight (US)
  • The Female Health Company (US)
  • Mayer Laboratories (US)
  • Cooper Surgical (US)

Contraceptive Pills Market Segmentation

Contraceptive Pills market has been segmented on the basis of drug class which comprises combination pills and Progestin only pills. Combination pills are further segmented into Monophasic and Multiphasic pills.

Contraceptive Pills Market Regional Analysis

Geographically, North America commands the largest market for the contraceptive pills market. Approximately 3 million women in North America experiences unplanned pregnancy. Beside this 90 % of the women use some of the method of contraception. Thus increasing number of abortion and rate of unplanned pregnancy has driven this market in North America. Major market of North America is contributed by US which is followed by Canada. Increasing awareness and minimizing the healthcare expenses by curbing number of abortion in US encourage contraceptive use among women. North America contraceptives drug market is expected to grow at a CAGR of 5.9 % during forecasted period.

Global Contraceptive pills Market – Competitive Analysis

The market for contraceptive pills is characterised by the presence of several well-established and small players, the global market of contraceptive pills appears to be highly competitive and fragmented. Major players are increasingly expanding their footprint in the emerging nations, making it putting pressure on the regional players, especially in terms of features such as type, product portfolios, and pricing. The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The contraceptive pills market appears to be highly competitive owing to the presence of several large and small key players accounting for a substantial market share. Well established players are getting into various product launches in order to gain competitive advantage in this market and to maintain their market position.

For instance, in 2015, Pfizer Inc. has introduced SAYANA, first injectable contraceptive in UK which can be self-administered.

While, in 2015, Teva Pharmaceutical Industries Ltd. has launched Beyaz which is a generic contraceptive drug. It is one of the most successful product of the company and in 2016 it has annual sales of approximately $133 million in the US. Recently, in March 2017, the company has launched a new product Minastrin in the market. Moreover, the company has launched the generic version of Janssen’s birth control pills Ortho Tri-Cyclen Lo. Into the brand name of Tri-Lo-Sprintec (norgetimate and ethinyl estradiol) tablets.

Table Of Content

1 INTRODUCTION

1.1 DEFINITION

1.2 SCOPE OF STUDY

1.2.1 RESEARCH OBJECTIVE

1.2.2 ASSUMPTIONS & LIMITATIONS

1.2.2.1 ASSUMPTIONS

1.2.2.2 LIMITATIONS

1.3 MARKET STRUCTURE

2 RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS:

2.2 PRIMARY RESEARCH

2.3 SECONDARY RESEARCH

3 MARKET DYNAMICS

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 MACROECONOMIC INDICATORS

     TOC Continued….!

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/contraceptive-pills-market-2122